Precision

Lyndra Therapeutics, Inc., based in Watertown, MA, is pioneering long-acting oral therapies aimed at transforming the patient experience by reducing the burden of daily medication regimens. Their innovative LYNX drug delivery platform has the potential for broad applicability across multiple therapeutic areas, including both approved and developing drugs. Generated from the website

Kano Therapeutics Inc, based in Cambridge, MA, is pioneering advancements in cell therapy through its innovative TFome platform, which leverages cutting-edge technologies in synthetic biology, gene editing, and machine learning. This groundbreaking approach enables the production of induced pluripotent stem cell (iPSC) therapies at a significantly accelerated pace, enhancing efficiency, quality, and accessibility for patients across various therapeutic areas. With a dedicated team of visionary scientists and operators, Kano Therapeutics is focused on developing best-in-class cell therapy programs targeting gastrointestinal, neurological, and immunological diseases. Their commitment to pushing scientific boundaries aims to deliver transformative treatments that can significantly improve patient outcomes. Generated from the website